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Mitochondria are dynamic organelles that alter their morphology in response to cellular signaling
and differentiation through balanced fusion and fission. In this study, we found that the mitochon-
drial inner membrane ATPase ATAD3A interacted with ccdc56/MITRAC12/COA3, a subunit of the
cytochrome oxidase (COX)-assembly complex. Overproduction of ccdc56 in HeLa cells resulted in
fragmented mitochondrial morphology, while mitochondria were highly elongated in ccdc56-
repressed cells by the defective recruitment of the fission factor Drp1. We also found that mild
and chronic inhibition of COX led to mitochondrial elongation, as seen in ccdc56-repressed cells.
These results indicate that ccdc56 positively regulates mitochondrial fission via regulation of COX
activity and the mitochondrial recruitment of Drp1, and thus, suggest a novel relationship between
COX assembly and mitochondrial morphology.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Mitochondria are double membrane-bound organelles with
essential roles in diverse metabolic and signaling pathways [1],
and have extremely different morphologies depending on cell
type. Even in the same cell, such as mammalian fibroblasts,
mitochondria can exhibit a range of morphologies, from small
spheres or short rods to long tubules. The overall shape of mito-
chondria is regulated by fusion and fission, and several compo-
nents of the core machinery for fusion (Mfn1, Mfn2, and OPA1)
and fission (Drp1 and the mitochondrial receptors Mff, MiD49,
and MiD51) have been identified in mammalian cells [2–5]. Inthe absence of fusion (for example, in Mfn1 and -2 double null
mutant cells), ongoing fission events result in the formation of
fragmented mitochondria, while a decrease of fission relative
to fusion (for example, in cells expressing a dominant negative
form of Drp1) results in elongated mitochondria. As well as con-
trolling the shape of mitochondria, fusion and fission are crucial
for maintaining their function, including respiratory capacity,
and play key roles in mammalian development [6], several neu-
rodegenerative diseases [6], and apoptosis [7]. Although several
components of the core fusion and fission machinery have been
identified, the detailed mechanisms and regulation of mitochon-
drial fusion and fission remain to be elucidated. In this study, we
identified a mitochondrial membrane protein, coiled-coil
domain-containing protein 56 (ccdc56), as a protein that regu-
lates mitochondrial fission.
2. Materials and methods
2.1. Antibodies
The following commercial antibodies were used: mouse
monoclonal anti-DNA (Progen); anti-Drp1 (BD Transduction);
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anti-MTCO2 (COX II), and MitoProfile Total OXPHOS Rodent WB
Antibody Cocktail (Abcam); rabbit monoclonal anti-COX IV, anti-
GAPDH, and rabbit polyclonal anti-Drp1 (pS637) (Cell Signaling);
rabbit polyclonal anti-Tom20, -anti-HSP60, anti-HA, and a mouse
monoclonal anti-actin and anti-myc (Santa Cruz); anti-protein
disulfide isomerase (PDI) (Stressgen); anti-Mff (Proteintech).
Rabbit polyclonal anti-Tom40 antibodies were a kind gift from
Drs. Katsuyoshi Mihara (Kyushu University) and Toshihiko Oka
(Kyushu University). Rabbit polyclonal antibodies against ATAD3
[8] were described. Horseradish peroxidase-conjugated secondary
antibodies were purchased from BIOSOURCE or Molecular Probes.
Alexa Fluor 488-, 568-, or 660-labeled goat anti-mouse IgG, IgM
or anti-rabbit IgG were purchased from Molecular Probes.
2.2. Cell culture
HeLa cells and HeLa cells expressing mitochondria-targeted
DsRed (mitRFP) [9] were cultured in ES medium (Nissui Pharma-
ceutical Co.) supplemented with 6% fetal bovine serum (FBS)
(SIGMA), penicillin G (100 units/ml), and streptomycin sulfate
(100 lg/ml), or in Dulbecco’s modified Eagle’s medium (Wako)
supplemented with 10% FBC (Invitrogen) under a 5% CO2 atmo-
sphere at 37 C.
2.3. Plasmid construction and transfection
To construct a HA-tagging plasmid, a DNA fragment encoding
an HA epitope tag followed by a stop codon was amplified by
PCR using primer-template oligonucleotides 50-CCAGCA
CAGTGGCGGCCGCTCGAGTACCCATACGACGTACCAGAT-30 and 50-T
TCGAAGGGCCCTCTAGATCAAGCGTAATCTGGTACGTCGTATGGGTA-30,
digested with NotI and Xbal, and then inserted to the pcDNA3.1/
myc-His A vector (Invitrogen) at the NotI and XbaI sites. The result-
ing vector was designated as pcDNA3.1/HA. To construct a plasmid
encoding C-terminally HA tagged ccdc56, a cDNA fragment
encoding ccdc56 was amplified from the pGADT7 plasmid carrying
ORF of ccdc56 (Clontech) by PCR using a forward primer
(ATTGAATTCGCCATGGCGTCTTCGGG) containing an EcoRI site and
a reverse primer (ATTCTCGAGGGACCCTGACGCCCTTGCCA) contain-
ing an XhoI site. The PCR products were digested with EcoRI and
XhoI, and then inserted in-frame into pcDNA3.1/HA using the
corresponding restriction enzyme sites, which yielded pcDNA3.1-
ccdc56-HA. Transfection of HeLa cells with pcDNA3.1-ccdc56-HA
was performed using Lipofectamine 2000 (Invitrogen) according
to the manufacturer’s instructions.
2.4. Subcellular localization of ccdc56
HeLa cells transfected with an ccdc56-HA expression plasmid
were washed with PBS, scraped off and then suspended in a
homogenization buffer (10 mM HEPES-KOH (pH 7.4), 70 mM
sucrose, and 0.22 M mannitol) containing a protease inhibitor
cocktail (Complete EDTA-free (Roche Diagnostics)). The cell sus-
pension was passed 30 times through a 27-gauge needle. After
brief centrifugation (900g, 5 min), the supernatant was cen-
trifuged at 5000g for 10 min. The resultant pellet was resus-
pended in the original volume of the homogenization buffer and
saved as the mitochondrial fraction. The resultant supernatant
was further centrifuged at 100000  g for 60 min to obtain micro-
somal and cytosolic fractions. The microsomal fraction pellet was
resuspended in the original volume of the homogenization buffer
and saved. Proteins in equal volumes of the total, mitochondrial,
microsomal and cytosolic fractions were separated by SDS–PAGE,
and Western blot detection was then performed with various
antibodies.2.5. Extraction of ccdc56 from mitochondria
The mitochondrial fraction was centrifuged at 5000g for
10 min, and the pellet was resuspended in control buffer (40 mM
Tris–HCl (pH 7.4), 150 mM NaCl), the same buffer containing 1%
Triton X-100, or 0.1 M Na2CO3 buffer (pH 11.5). The suspension
was incubated at 4 C for 30 min and then centrifuged for 30 min
at 100000g, and the resulting pellet was resuspended in the orig-
inal volume of homogenization buffer. Proteins in equal volumes of
the pellet and supernatant fractions were separated by SDS–PAGE,
and Western blot detection was then performed with various
antibodies.
2.6. RNA interference
Two short-interfering RNA (siRNA) duplexes targeting human
ccdc56 (siGENOME: ‘‘siRNA-1” and ‘‘siRNA-3”) as well as a non-
targeting siRNA (siCONTROL Non-Targeting siRNA #2 D-001210-
02) were purchased from Dharmacon. The target sequences of
siRNAs ‘‘ccdc56-R1” and ‘‘ccdc56-R2” were 50-GAAGCUGACACCCGAG
CAA-30 and 50-GGUUACACCUUCUACUCGA-30, respectively (Bonac).
To examine mitochondrial morphology, HeLa cells were trans-
fected with control non-targeting siRNA duplex or ccdc56-
targeting siRNA duplexes, using Lipofectamine 2000 or RNAiMAX
(Invitrogen) according to the manufacturer’s instructions. After
two days, the cells were transfected again and cultured for a fur-
ther two days. At two days or four days after the first transfection,
the indirect immunofluorescence assay was carried out. Mock-
transfected cells were prepared by the same procedure without
siRNA duplexes.
To test the efficiency of ccdc56-depletion by siRNAs, 2  104
HeLa cells were seeded into the wells of a 24-well plate in Opti-
MEM (Invitrogen) supplemented with 10% FBS, and after incuba-
tion for 24 h, the cells were cotransfected with plasmid
pcDNA3.1-ccdc56-HA encoding ccdc56-HA (0.4 lg) and 10 pmol
of a non-targeting siRNA duplex or a mixture of two ccdc56-
targeting siRNA duplexes, using Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s instructions. After two days incu-
bation, the cells were lysed for immunoblot analysis. RT-PCR,
immunoprecipitation, immunofluorescence analysis, SDS–PAGE
and immunoblotting were analyzed as described previously [9,10].3. Results and discussion
We identified human ccdc56, also known as MITRAC12 or COA3
[11–13], through a yeast two-hybrid system as a protein that inter-
acts with the mitochondrial protein ATAD3 (also called AAA-TOB3),
which has been suggested to play a role in tumor progression
[14,15], and to be associated with mitochondrial DNA (mtDNA)
nucleoids [16–18]. We confirmed their physical interaction in HeLa
cells by co-immunoprecipitation experiments after crosslinking
(Fig. 1A). Full-length cDNA clones of human ccdc56 were found
previously on large-scale cDNA sequencing [19,20], and its
sequence predicts a protein of 106 amino acid residues, which is
conserved in chimpanzee, dog, cow, mouse, rat, chicken, and zebrafish
(Fig. 1B). Ccdc56 was reported as a mitochondrial membrane
protein [11–13], and we confirmed that ccdc56-HA transiently
expressed in HeLa cells was localized in the mitochondria, as
described below. Immunofluorescence microscopic analysis
showed that ccdc56-HA colocalized with mitochondrial RFP or
ATAD3A (Fig. 1E). When a post-nuclear supernatant of HeLa cells
producing ccdc56-HA was fractionated into mitochondrial, micro-
somal, and cytosolic fractions, ccdc56-HA was recovered in the
mitochondrial fraction containing the mitochondrial marker pro-
tein Tom40 (Fig. 1C). In contrast, ccdc56-HA was undetectable in
Fig. 1. Ccdc56 interacts with ATAD3A in mitochondria and affects mitochondrial morphology. (A) HeLa cells were transfected with human ccdc56-HA and ATAD3A variant 2-
myc. The cells were treated with 1% formaldehyde for 10 min, immunoprecipitated with an anti-HA antibody, then analyzed by immunoblotting with the indicated
antibodies. (B) Multiple sequence alignment of the predicted amino acid sequences of the ccdc56 proteins of human (NP_001035521.1⁄), chimpanzee (XP_001160561.1⁄), dog
(XP_537635.1⁄), cow (NP_001029855.1⁄), mouse (NP_080894.1⁄), rat (XP_573196.1⁄), chicken (XP_001234221.1⁄), and zebrafish (NP_001108388.1⁄), performed with the
ClustalW2 program, is shown. A transmembrane segment predicted with the TMHMM algorithm is underlined. Amino acid residues forming a coiled-coil domain are shown
in red letters. *NCBI reference sequences. (C) Total lysate (T) from HeLa cells producing ccdc56-HA was fractionated into mitochondrial (Mt), microsomal (Ms), and cytosolic
(Cyt) fractions. These fractions were subjected to immunoblotting analysis using antibodies against the HA epitope, mitochondrial outer-membrane protein Tom40, ER
protein PDI, and cytosolic protein actin. (D) The mitochondrial fraction prepared from HeLa cells producing ccdc56-HA was suspended in a buffer (40 mM Tris–HCl pH 7.4,
150 mM NaCl) (Control), the same buffer containing 1.0% Triton X-100 (TX-100), or 0.1 M Na2CO3 buffer (pH 11.5) (Na2CO3), centrifuged to obtain the supernatant (S) and
pellet (P) fractions, and then analyzed by immunoblotting with antibodies against the HA epitope, integral membrane protein Tom40, and mitochondrial matrix protein
HSP60. (E) HeLa cells stably expressing mitochondrial RFP or normal HeLa cells were transfected with the indicated expression plasmids. These cells were fixed,
permeabilized, and then immunostained with antibodies against HA, myc or ATAD3A. Images were acquired by confocal microscopy. Enlargements are presented to show
structural details. (F) HeLa cells transfected with the ccdc56-HA expression plasmid were subjected to indirect immunofluorescence analysis with a monoclonal anti-HA
antibody and polyclonal anti-PDI antibodies, and then analyzed by confocal microscopy. (G) Percentages of cells having normal, fragmented, elongated, or aggregated
mitochondria among untransfected cells (Control) and cells overproducing ccdc56-HA. The data represent the mean ± standard deviation (S.D.) of three independent
experiments (100 cells scored per experiment).
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plasmic reticulum (ER) marker protein PDI and the cytosolic mar-
ker protein actin (Fig. 1C). According to the SOSUI and TMHMM
algorithms, ccdc56 is predicted to have a single transmembrane
segment. To determine whether ccdc56 is an integral membrane
protein, mitochondria of HeLa cells producing ccdc56-HA were
subjected to alkaline (0.1 M Na2CO3) and detergent (1% Triton
X-100) treatment, followed by ultracentrifugation. Upon alkaline
treatment, the majority of ccdc56-HA was found in the membrane
pellet fraction (Fig. 1D). In addition, the majority of ccdc56-HA wasreleased into the supernatant upon detergent treatment followed
by ultracentrifugation. This behavior of ccdc56-HA resembled
that of the integral membrane protein Tom40, but was different
from that of the matrix protein HSP60 (Fig. 1D). These results
confirmed that ccdc56 is a mitochondrial membrane protein,
consistent with the data showing this protein interacts with the
inner membrane protein ATAD3 (Fig. 1A) and previous reports
showing that ccdc56 is a subunit of the assembly factor of cyto-
chrome c oxidase (COX) in the mitochondrial inner membrane
[11–13].
Fig. 2. Ccdc56 regulates mitochondrial morphology, but not mtDNA nucleoid structure, in HeLa cells. (A) HeLa cells transfected with a ccdc56-HA expression plasmid were
treated with ccdc56-targeting siRNA duplexes (mixture of siRNA-1 and siRNA-3) or a control non-targeting siRNA duplex, or subjected to mock treatment, and then the
production of ccdc56-HA was analyzed by immunoblotting using anti-HA antibodies. Different lanes from the same blot are shown. (B) HeLa cells were mock transfected or
transfected with the control or ccdc56 siRNAs (1 + 3). After a 96-h incubation, the cells were subjected to indirect immunofluorescence analysis using the indicated
antibodies. Tom20 is a mitochondrial protein (red). Anti-DNA specifically stained mtDNA (green). (C) The cells were stained and observed by confocal microscopy. Percentage
of cells having normal, fragmented, elongated, or aggregated mitochondria. The data represent the mean ± S.D. of three independent experiments (100 cells scored per
experiment). (D) HeLa cells were treated with ccdc56-targeting siRNA (siRNA-R1 or siRNA-R2) or a control siRNA for 96 h. The production of ccdc56 mRNA was analyzed by
RT-PCR. (E) Repression of ccdc56 proteins was checked as in (A). (F) HeLa cells were transfected with the control or indicated siRNAs, cultured for 48 h or 96 h, and then
subjected to indirect immunofluorescence analysis as in (B).
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we noticed that overproduction of ccdc56-HA resulted in aberrant
mitochondrial morphology. As shown in Fig. 1E, HeLa cells over-
producing ccdc56-HA (‘‘high exp.”) had fragmented mitochondria,
instead of normal interconnected tubular mitochondria seen in
cells moderately expressing ccdc56-HA (‘‘low exp.”).
Overexpression of ATAD3A also led to mitochondrial fragmen-
tation similar to that observed for ccdc56 overexpression
(Fig. 1E), as reported [8]. Quantitative analysis revealed that upon
transient transfection with a ccdc56-HA expression plasmid,
approximately 80% of HeLa cells producing ccdc56-HA contained
fragmented mitochondria, whereas among the untransfected cells,
such mitochondrial morphology was observed rarely (Fig. 1G). In
contrast to the morphology of mitochondria, that of the ER was not
affected by overproduction of ccdc56-HA, as observed on stainingfor the ER marker protein PDI (Fig. 1F), suggesting a specific effect
of ccdc56-HA overproduction on mitochondrial morphology.
Next, we examined the effect of ccdc56 depletion by the intro-
duction of ccdc56-targeting short-interfering RNA (siRNA) on
mitochondrial morphology. To examine depletion efficiency, HeLa
cells transfected with a ccdc56-HA expression plasmid were trea-
ted with ccdc56-specific siRNA or a control non-targeting siRNA,
or subjected to mock treatment, and then the production of
ccdc56-HA was analyzed by immunoblotting using anti-HA anti-
bodies. As shown in Fig. 2A and E, treatment with the ccdc56-
targeting siRNA, but not with the control siRNA or mock treatment,
resulted in the almost complete inhibition of ccdc56-HA produc-
tion, indicating the effectiveness of the ccdc56-targeting siRNA.
When mitochondrial morphology was analyzed, the majority of
ccdc56-depleted HeLa cells exhibited aberrant mitochondria with
Fig. 3. Defective Drp1 targeting to mitochondria in ccdc56-deficient HeLa cells. (A and B) HeLa cells were treated with ccdc56-targeting siRNA (siRNA-R1 or siRNA-R2) or a
control siRNA for 96 h. These cells were immunostained with the indicated antibodies. Tom20 and Tom22 were used as mitochondrial markers. Large Drp1 punctate
structures were observed on the mitochondria of control cells (arrowheads), whereas smaller Drp1 puncta were observed in the cytoplasm (arrows) of ccdc56 siRNA-treated
cells. (C) HeLa cells were transfected with ccdc56 or control siRNA, immunoprecipitated with an anti-Drp1 antibody, then analyzed by immunoblotting with the indicated
antibodies. Forskolin was used as positive control. (D) HeLa cells were transfected with human ccdc56-HA with FLAG-tagged Mff, Fis1, MiD49, or MiD51. The cells were
treated with 1% formaldehyde, immunoprecipitated with an anti-FLAG antibody, then analyzed by immunoblotting with anti-HA antibody.
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Upon quantitative analysis, such aberrant mitochondria were
observed in approximately 70% of the ccdc56-depleted cells, butwere observed rarely in control siRNA-treated or mock-treated
cells (Fig. 2C). This effect of ccdc56 depletion was suggested to
be specific to mitochondrial morphology, because ccdc56-depleted
Fig. 4. COX assembly is partially defective in ccdc56-repressed cells, and mild COX inhibition leads to mitochondrial elongation. (A and B) HeLa cells treated with ccdc56-
siRNA were analyzed by immunoblotting using the indicated antibodies. The expression of mitochondrial fission factors was normal (A), but the expression of the COX
subunit COX II was partly diminished (indicated by the red rectangle). (C) Immunostaining using an anti-COX I antibody also supported the presence of partial defects in COX
assembly. (D) HeLa cells were treated with 1 or 5 mM KCN for the indicated times, and mitochondrial morphology was analyzed by fluorescence microscopy. (E) HeLa cells
were treated with 0.25 or 5 mM CoCl2 for the indicated times, and mitochondrial morphology was analyzed by fluorescence microscopy. (F) HeLa cells expressing
mitochondrial RFP were treated with 1 mM KCN for 96 h, and these cells were immunostained with anti-Drp1 antibodies. Drp1 puncta/aggregates were observed in the
cytoplasm (arrows) in KCN-treated cells. (G) HeLa cells were treated with KCN as above, then these cells were treated with 1% formaldehyde, immunoprecipitated with an
anti-Mff antibody, then analyzed by immunoblotting with the indicated antibodies.
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We further confirmed the repression of ccdc56 by RT-PCR
(Fig. 2D), and which caused mitochondrial elongation (Fig. 2F)
in HeLa cells treated with siRNAs to other target sequences of
ccdc56.
Next, we analyzed the role of ccdc56 in mitochondrial morpho-
genesis. ATAD3 is a component of mtDNA nucleoids and plays a role
in mtDNA maintenance [21]. However, the distribution of mtDNA
nucleoids was not affected in ccdc56-repressed cells
(Fig. 2B and C). It was reported that in ATAD3 repressed cells, mito-
chondrial morphology was less affected, or changed to small and
fragmented mitochondria [17]. ATAD3 is known to be a multifunc-
tional proteins [14–18,21], which might cause the different pheno-
type with that of ccdc56. Next, we analyzed the mitochondrial
fission factor Drp1, which is a high-molecular-weight GTPase pro-
tein recruited from cytosol to mitochondrial fission sites that stim-
ulates mitochondrial fission [5]. When we stained for Drp1 in
control HeLa cells, many punctate structures were observed on the
mitochondria (Fig. 3A, arrowheads). However, fewer Drp1 punctawere observed on the mitochondria of ccdc56-repressed cells, and
instead, many small puncta were observed in cytosol (Fig. 3A,
arrows). The expression level of Drp1 was normal in the ccdc56-
repressed cells (Fig. 4A). Neither the expression (Fig. 4A) nor the dis-
tribution (Fig. 3B) of Mff, a mitochondrial receptor of Drp1, was
affected. These data suggest that ccdc56 affects the mitochondrial
targeting of Drp1. We then further analyzed molecular mechanism
howmitochondrial morphology is regulated by ccdc56. Phosphory-
lation of Drp1 at Ser-637, which was modified under starvation
condition [22], was not affected by ccdc56-repression (Fig. 3C),
suggesting that the mitochondrial morphology change was not
caused by energy exhaustion. Next we examined physical
interaction of ccdc56withmitochondrial fission factors by immuno-
precipitation after cross-linking, and found that ccdc56 was
co-precipitated with Drp1 receptors, Mff, MiD49, and MiD51, and a
mitochondrial morphology protein Fis1 (Fig. 3D). Interestingly, ccd-
c56 was most efficiently recovered with Fis1 among these proteins,
and Fis1-repressed cells, aswell as ccdc56-repressed cells, exhibited
aberrant mitochondria with elongated tubules (Fig. 2F). These data
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phology factors, although it remains as an open question how inner
membrane ccdc56 interacts with these outer membrane factors.
Recently, it was reported that ccdc56 mediates COX assembly
[11–13]. COX II, analyzed by immunoblotting (Fig. 4B), and COX I,
analyzed by immunofluorescence microscopy (Fig. 4C), were partly
diminished in ccdc56-repressed cells, as shown previously [11–13].
It is well known that treatment with respiratory inhibitors, such as
the protonophore CCCP or ATPase inhibitor oligomycin, leads to
mitochondrial fragmentation by inhibiting Opa1-dependent mito-
chondrial fusion [23]. To elucidate the role of COX in mitochondrial
morphology, we examined the effect of the COX inhibitor potas-
sium cyanide (KCN) on mitochondrial morphology. When HeLa
cells were treated with 5 mM KCN, the mitochondria fragmented
immediately, as expected (Fig. 4D), and the cells died within several
hours, possibly by severe COX inhibition. However, when COX
activity was inhibited mildly by 1 mM KCN, the mitochondria were
clearly and severely elongated after 4 days (Fig. 4D), suggesting that
mild and chronic impairment of COX caused mitochondrial elonga-
tion, and which may correspond to the ccdc56-inhibition-induced
mitochondrial elongation. We analyzed another COX-inhibiting
condition by treating lower concentration of CoCl2, which mimic
hypoxia to block COX activity, and further confirmed that mild
COX inhibition leads to mitochondrial elongation (Fig. 4E). In the
KCN-treated cells, Drp1 was mislocalized in cytosol and formed
punctate or aggregated structures (Fig. 4F). Furthermore, interac-
tion between Drp1 and the mitochondrial receptor Mff was dimin-
ished (Fig. 4G). These data further support the conclusion that mild
COX inhibition affects Drp1 localization and mitochondrial
morphology.
Thus, we found that overproduction of ccdc56-HA induced frag-
mentation of mitochondria, and conversely, depletion of ccdc56
induced elongation of mitochondria and reduced the mitochondrial
recruitment of Drp1. These data indicate that ccdc56 positively reg-
ulates mitochondrial fission. We further found that mild inhibition
of the respiratory COX complex led to mitochondrial elongation.
This is the first report to show a link between a COX assembly factor
and mitochondrial fission. Ccdc56 interacts with the nucleoid pro-
tein ATAD3; however, ccdc56 had less of an impact on nucleoid dis-
tribution, suggesting that ATAD3 should have multiple functions,
not only in mtDNA assembly but also affecting the COX assembly
complex. It is an interesting question how the innermembrane pro-
tein ccdc56 regulates Drp1 targeting to the outer membrane, with-
out affecting Mff. It might be possible that a partial COX defect
induces a cellular stress response that affects mitochondrial mor-
phology, as stress-induced mitochondrial hyperfusion [24]. How-
ever, the COX deficiency affected Drp1 recruitment, which is
different from the mitochondrial hyperfusion regulated by Opa1
processing. Although the detailed molecular mechanism of how
ccdc56 affects Drp1 targeting are unknown, further study of the
function of ccdc56 will provide new insights into the mechanism
and regulation of mitochondrial fission and biologically significant
processes related to mitochondrial dynamic morphology, such as
respiration, mammalian development, neurodegenerative diseases,
and apoptosis.
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